Teladoc Health Inc., the world's largest telehealth company, is currently valued at approximately $1.2 billion to $1.5 billion market capitalization, trading near its all-time low. The company owns BetterHelp, the leading brand in online therapy, which historically operated on a cash-pay only model that limited conversion rates. Recent analysis suggests that a shift in BetterHelp's monetization strategy could unlock greater value. Market observers, including Citron Research and other investors, predict that Teladoc could experience a turnaround similar to that of Carvana, with potential to double or triple its stock price from current levels. Teladoc is noted for its low price-to-sales ratio of around 0.5x compared to an 8-9x median in the sector, positive free cash flow expected in 2024, and an overlooked position in artificial intelligence applications. The company is also heavily shorted, adding to the asymmetric risk and reward profile. Citron Research anticipates that Teladoc may be acquired by private equity firms that could better monetize its patient base.